teaser
Roche has presented yet more positive data from the third late-stage study of its experimental compound for rheumatoid arthritis, Actemra
This site is intended for health professionals only
teaser
Roche has presented yet more positive data from the third late-stage study of its experimental compound for rheumatoid arthritis, Actemra